Concepedia

Diba Latifi

DL

4

Publications

103

Citations

4

H-Index

2018

Active since

Affiliations

Erasmus MC(Current)

Diba Latifi is an author at Erasmus MC specializing in medicine, tumor immunity, and immune regulation.

ORCID

Top concepts

Publications per year

2018–2022

4

Publications

4

Early results after operatively versus non-operatively treated flail chest: a retrospective study focusing on outcome and complications

Mathieu M. E. Wijffels, Tjebbe Hagenaars, Diba Latifi et al. · European Journal of Trauma and Emergency Surgery · 2018 · 54 citations · Full text

Survival Benefit Associated With Resection of Locally Advanced Pancreatic Cancer After Upfront FOLFIRINOX Versus FOLFIRINOX Only

L. Brada, Lois A. Daamen, L. Magermans et al. · Annals of Surgery · 2021 · 22 citations · Full text

Identification, Validation, and Utilization of Immune Cells in Pancreatic Ductal Adenocarcinoma Based on Marker Genes

Willem de Koning, Diba Latifi, Yunlei Li et al. · Frontiers in Immunology · 2021 · 15 citations · Full text

Rintatolimod (Ampligen®) Enhances Numbers of Peripheral B Cells and Is Associated with Longer Survival in Patients with Locally Advanced and Metastasized Pancreatic Cancer Pre-Treated with FOLFIRINOX: A Single-Center Named Patient Program

Hassana el Haddaoui, Rianne Brood, Diba Latifi et al. · Cancers · 2022 · 12 citations · Full text

, , +21

Rows per page

1–4 of 4